Proper oxygen metabolism is vital for heart health, particularly for patients with ischemic conditions like stable angina. The Cardio MedBed, a revolutionary non-invasive therapy, has shown significant improvements in myocardial oxygen metabolism, leading to long-term symptom relief for angina patients.
This article reviews key clinical trials that underscore the therapy’s effectiveness in enhancing oxygen utilization and providing sustained benefits.

1. Enhancing Oxygen Metabolism in Ischemic Myocardium (March 2004)
A clinical trial published in Heart and Vessels in March 2004 investigated the effects of Cardio MedBed therapy combined with heparin pre-treatment on regional myocardial oxygen metabolism in patients with stable angina.
Key Findings:
Increased Oxygen Metabolism in Ischemic Regions: The study measured the k mono index, a marker of oxygen utilization in the heart’s ischemic regions. This index increased significantly from 0.038 ± 0.004 to 0.053 ± 0.007 (P << 0.05), indicating improved oxygen metabolism.
Selective Targeting of Ischemic Areas: The therapy selectively improved oxygen delivery and utilization in ischemic regions without affecting non-ischemic areas, ensuring a focused and safe treatment approach.
These findings highlight Cardio MedBed’s ability to optimize oxygen metabolism in areas most affected by ischemia, making it a promising treatment for stable angina.
2. Sustained Angina Relief Across Diverse Populations (June 2012)
A comparative study published in Turkish Archives of Cardiology in June 2012 examined the long-term outcomes of Cardio MedBed therapy in angina patients from the United States and Turkey.
Key Findings:
Reduction in Angina Severity: Patients in both cohorts experienced significant improvements in angina symptoms after completing 35 hours of therapy, regardless of their initial risk profiles.
Long-Term Symptom Relief: The benefits persisted during follow-up, with a low incidence of major adverse cardiac events (MACE) reported in both populations.
Universal Effectiveness: Despite differences in demographics and baseline characteristics, the therapy consistently delivered positive clinical outcomes.
These results confirm Cardio MedBed’s efficacy in managing stable angina across diverse patient populations, offering lasting relief and improved quality of life.
Optimizing Oxygen Utilization and Sustained Symptom Relief
Cardio MedBed therapy stands out as an innovative solution for improving oxygen metabolism in ischemic regions of the heart while delivering durable angina relief. By targeting the root causes of ischemia and demonstrating effectiveness across various populations, this non-invasive therapy has become a cornerstone of cardiovascular care.
For patients struggling with stable angina, Cardio MedBed therapy offers renewed hope and proven benefits, from immediate symptom relief to long-term improvements in heart health. To learn more, explore the studies linked above and discover the transformative potential of this groundbreaking treatment.
With the purchase of every Cardio MedBed comes the chance to participate in the New World Practitioner Certification FOR FREE! Go to DODPOWERPACK.COM for more information on these certifications.